Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 5/20 | 0.45 |
| ▸ | HTR1A | P08908 | 4/20 | 0.45 |
| ▸ | HTR2A | P28223 | 4/20 | 0.45 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | HRH1 | P35367 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL293244 | 0.80 | DRD2 (0.68) | DRD2HTR1AHTR2AHTR2CADRA1A | |
| SCHEMBL4629548 | 0.79 | DRD2 (0.34) | DRD2HTR1AHTR2AHTR2CADRA1A | |
| SCHEMBL4629376 | 0.77 | DRD2 (0.33) | DRD2HTR1AHTR2A | |
| Hydrochloric Acid SCHEMBL4631048 | 0.77 | HTR1A (0.33) | DRD2HTR1AHTR2AHTR2CADRA1A | |
| Hydrochloric Acid SCHEMBL4630605 | 0.77 | HTR1A (0.33) | DRD2HTR1AHTR2AHTR2CADRA1A | |
| SCHEMBL5504510 | 0.72 | HTR1A (0.38) | DRD2HTR1AHTR2AHTR2CADRA1A | |
| SCHEMBL4630514 | 0.72 | DRD2 (0.33) | DRD2HTR1AHTR2AHTR2CADRA1A | |
| SCHEMBL5511426 | 0.71 | HTR1A (0.37) | DRD2HTR1AHTR2AHTR2CADRA1A | |
| SCHEMBL513130 | 0.70 | DRD2 (0.66) | DRD2HTR1AHTR2AHTR2CADRA1A | |
| SCHEMBL20915099 | 0.70 | DRD2 (0.46) | DRD2HTR1AHTR2AHTR2CADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1919907-A2 | HETEROCYCLIC COMPOUND | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2008-05-14 | — | — | EP | disclosed |
| WO-2007026959-A2 | DERIVATIVES OF 4-PIPERAZIN-1-YL-4-BENZ0 [B] THIOPHENE SUITABLE FOR THE TREATMENT OF CNS DISORDERS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-03-08 | — | — | WO | disclosed |